Results

Total Results: 1,492 records

Showing results for "harm".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
    October 05, 2018 - Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Long-term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention Initial publication date: April 13, 2018 Amendment Date: October 5,…
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-224-depression-children-comments.pdf
    April 10, 2020 - Public reviewer: AACAP Analysis of Number Needed to Harm or Treat For other conditions, epidemiological … measures are used that indicate the number needed to harm (NNH) and number needed to treat. … TEP member #1 Results I am glad that there was an explicit discussion about suicidality as a harm on … We have added a table for numbers needed to treat and harm, and we hope that this table will help focus
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_executive.pdf
    April 01, 2015 - not at reducing the occurrence of PPH but at diminishing associated morbidity, mortality, personal harm
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
    January 09, 2020 - EHC Research Protocol (Amended): Treatments for Acute Episodic Migraine 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Acute Treatments for Episodic Migraine Initial Publication Date: January 8, 2020 Amendment Date: January 9, 2020 (Amendments Details-see Section VII) I. Backgro…
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
    November 02, 2018 - Table 1 Confusion listed as a treatment harm. … Table 1 Mortality listed as a treatment harm. Changed to mortality (all- cause, CVD, non-CVD).
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - 1 Comparative Effectiveness Review Number 37 Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment Executive Summary Objectives This systematic review evaluates the evidence regarding the potential benefits and harms of: (1) screening adults for early-stage chronic kidney disease (CKD stages…
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diverticulitis-research-protocol.pdf
    January 01, 2019 - The evidence regarding this potential harm has not been summarized to date.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-revised-comments.pdf
    November 12, 2020 - Disposition of Comments: CER 234 Management of Primary Headaches in Pregnancy Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Management of Primary Headaches in Pregnancy Draft review available for public comment from June 2, 2020 through June 30, 2020. …
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
    June 07, 2013 - restrictive range for ovarian cancer, it would seem that given one of the main goals was to assess the harm … We state in the beginning of the presentation of the acceptability curves (in the Harm/Benefit Acceptability … Section Comment Response Peer Reviewer 3 General The sentence “Overall, the model predicted that the harm … increased risk of untoward events, this also needs to be taken into account in calculating the benefit/harm … as though they were not comprehensive such as the complete elimination of pregnancy as a potential harm
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
    July 01, 2023 - What patient safety measures or indicators have been used to examine the harm associated with polypharmacy … What deprescribing interventions have been used to prevent or mitigate the harm and in what settings … What is the rationale for deprescribing to prevent or mitigate the harm? 5.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-opioid-stewardship-protocol.pdf
    July 01, 2023 - guidelines, noting a concern that previous guidance had been misapplied, leading to unintended patient harm … deciding duration, dosage and followup for prescriptions, and assessing risk and addressing potential harm … questions, and will include author, year, study design, frequency and severity of the harms, measures of harm
  13. effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-outpatient-setting-comments.pdf
    March 22, 2021 - Other examples of language that were improved was the use of the word “safe” when referring to harm … Conclusions are based on a total small sample that was unable to fully evaluate potential maternal or fetal harm … findings to the population of childbearing women in the United States will likely increase risk of harm
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
    April 01, 2019 - CER 218 Evidence Summary: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review Purpose of Review To summarize the effects of long-term osteoporosis drug treatment and of osteoporosis drug treatment discontinuation and holidays. Key Messages • Evidence on the effects …
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_executive.pdf
    September 01, 2014 - The major harm from PET/CT is radiation exposure. … PET/CT were appropriate, suggesting that using PET/CT for staging may result in significant patient harm … While all four imaging modalities appear to be reasonably safe, long-range harm from radiation exposure
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
    September 01, 2014 - Even when used under medical supervision, these products can cause serious harm, including dehydration
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
    January 01, 2013 - augmenting agents were given a rating of insufficient for evaluating both the outcomes of benefit and harm … grading SOE; the overall grade was assigned as insufficient for both the outcomes of benefit and harm … or 66 or 67 or 68 or 69 71 limit 70 to yr="2011 - 2012" 72 limit 48 to yr="2011 - 2012" 73 (harm … augmenting agents were given a rating of insufficient for evaluating both the outcomes of benefit and harm … grading SOE; the overall grade was assigned as insufficient for both the outcomes of benefit and harm
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
    March 23, 2019 - Treatments for primary headaches may harm the fetus and breastfed newborn. … Radiation and/or contrast agents may harm the fetuses of pregnant women who undergo diagnostic testing … abnormalities, drug- induced”[MESH] OR birth defect OR congenital abnormality OR ((adverse or undesirable or harm … analog” OR octreotide) AND (birth defect OR congenital abnormality OR ((adverse or undesirable or harm
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: July 28, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Screening for and Management of Chronic Kidney Disease Stages 1-3 I. Background and Objectives for the Systematic Review T…
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-disposition-comments.pdf
    August 29, 2023 - Disposition of Comments_Comparative Effectiveness Review No. 265_Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms Comparative Effectiveness Review Disposition of Comments Report Title: Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms Draft report ava…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: